In this Expert View column, Abbas Kazimi, chief business officer of Nimbus Therapeutics, discusses the advantages of a ...

San Francsiscan liver specialist 89bio (Nasdaq: ETNB) has secured $250 million through a public stock offering, following a ...

The global neuromuscular disease therapeutics market is projected to grow by $13.73 billion between 2025 and 2029, according ...

The use of the ESMP will become mandatory for MAHs and NCAs as of Sunday, February 2. The platform is a key requirement of ...

A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...

Swiss pharm giant Roche today announced that Wafaa Mamilli will join the company as chief digital technology officer (CDTO), ...

Days after the European Commission (EC) granted approval, the UK’s Medicines and Healthcare Regulatory Agency (MHRA) has ...

In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved ...

Independent French drugmaker Servier, which is governed by a foundation, has published its 2023/24 financial year results and ...

Biopharma start-up Helicore Biopharma has emerged from stealth with $65 million from a series A round co-led by Versant ...

Switzerland-based Lonza Group was trading nearly 3% lower by lunchtime Wednesday after presenting its financial results for ...

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...